Traitement Cancer du larynx en Chine — recevez 3 correspondances personnalisées de cliniques

Chinese hospitals use narrow-band imaging (NBI) and high-definition laryngostroboscopy to detect early-stage larynx cancer. For staging, centers utilize 3T MRI, dual-energy CT, and PET/CT scans. These protocols follow Chinese Society of Clinical Oncology (CSCO) guidelines to ensure accurate tumor mapping.

• Optical imaging: NBI and autofluorescence laryngoscopy highlight vascular changes and tumor boundaries.
• Radiology: High-resolution MRI with diffusion-weighted sequences detects subtle cartilage and tissue invasion.
• Advanced staging: PET/CT imaging identifies distant metastasis and occult cervical lymph node spread.
• Artificial intelligence: AI-driven systems like LPAIDS analyze endoscopic video with over 95% accuracy.

Bookimed Expert Insight: Diagnostic precision in China is driven by high patient volumes at tertiary centers. Xiamen Humanity Hospital serves around 1,000,000 patients annually. This massive scale allows specialists like Dr. Liu Shi Xin to refine staging accuracy. Major centers often integrate advanced PET/CT and MRI for complex cases before determining if voice-preserving surgery is possible.

Patient Consensus: Patients note that flexible laryngoscopy via the nose is typically the first step. They emphasize that while scans are helpful, direct laryngoscopy under anesthesia is vital for mapping and biopsy.

Voice-box preservation is standard in China through advanced surgical techniques. Leading facilities utilize partial laryngectomies and transoral laser surgery to remove tumors while protecting speech. Highly specialized teams also perform laryngeal transplants and subtotal reconstructions. These methods prioritize maintaining natural breathing and swallowing functions.

• Laser microsurgery: Surgeons use lasers through the mouth for early-stage tumor removal.
• Partial laryngectomy: Doctors remove only cancerous sections to maintain phonation and diet.
• Advanced reconstruction: Specialized centers rebuild airway pathways even in complex stage 4 cases.
• Integrated therapy: Surgeons often use immunotherapy first to shrink tumors before operating.

Bookimed Expert Insight: Patient volume significantly impacts surgical precision in China. Xiamen Humanity Hospital serves around 1,000,000 patients annually. High-volume centers often possess greater expertise in complex head-and-neck reconstructions. JCI-accredited facilities like Fuda Cancer Hospital focus on minimally invasive alternatives to radical surgery. This high caseload helps surgeons refine organ-preserving techniques that smaller clinics may not master.

Patient Consensus: Patients emphasize that voice-box preservation is possible but often results in a weaker or hoarser voice. Many suggest seeking second opinions at major cancer centers to confirm if a partial removal is oncologically safe.

Proton beam therapy is available and clinically safe for laryngeal cancer in specialized Chinese oncology centers. This advanced radiation targets tumors with extreme precision using the Bragg Peak effect. It stops at a defined depth. This prevents radiation from exiting through healthy throat tissues or vocal cords.

• Function preservation: Proton therapy preserves swallowing and vocal abilities by sparing healthy throat structures.
• Side effect reduction: Clinical data shows a 13% reduction in feeding tube reliance during treatment.
• Immune protection: Precise beams cause 15% less immune suppression than traditional X-ray radiation therapy.
• Available techniques: Specialized centers offer Intensity-Modulated Proton Therapy (IMPT) to protect the spinal cord.

Bookimed Expert Insight: Professional leadership is the most reliable quality signal in China. Xiamen Humanity Hospital is led by Dr. Liu Shi Xin. He is the Vice Chairman of the Particle Therapy Committee in China. This confirms the clinic operates at the highest national level for proton and particle treatments. This clinical integration often outweighs the mere presence of the technology itself.

Patient Consensus: Patients emphasize that voice preservation and nutrition are their top priorities. Many recommend asking how proton therapy specifically improves their anatomical plan compared to standard IMRT before starting.

Voice rehabilitation after total laryngectomy primarily involves three options: tracheoesophageal puncture (TEP), an electrolarynx, or esophageal speech. TEP with a voice prosthesis is the gold standard for natural sound. Success depends on anatomy, healing, and access to specialized speech-language pathologists.

• Tracheoesophageal puncture (TEP): A surgeon creates a tunnel for a one-way silicone valve prosthesis.
• Electrolarynx: This handheld battery-powered device creates vibrations to produce a mechanical voice instantly.
• Esophageal speech: Patients learn to expel swallowed air to vibrate throat tissues without devices.
• Clinical support: Specialized pathologists guide patients through a transition period to master chosen methods.

Bookimed Expert Insight: While TEP offers the most natural speech, centers like Xiamen Humanity Hospital focus on integrated oncology. Large facilities serving 1,000,000 patients annually often have higher access to multi-disciplinary teams. Reviewing whether a center offers minimally invasive options like cryosurgery or NanoKnife is vital. These technologies at Fuda Cancer Hospital suggest a focus on tissue preservation which aids recovery.

Patient Consensus: Patients note that the electrolarynx is a vital backup during the frustrating early recovery. Many emphasize that mastering voice care, including cleaning the prosthesis and managing stoma mucus, is a daily reality.

Immunotherapy is approved and available for larynx cancer in China. The National Medical Products Administration (NMPA) has authorized several immune checkpoint inhibitors. These treatments target recurrent or metastatic head and neck squamous cell carcinoma. This classification includes squamous cell cancers of the larynx.

• Approved drugs: NMPA-approved options include nivolumab and the recently authorized domestic drug finotonlimab.
• Domestic pipeline: Targeted agents like toripalimab and tislelizumab are frequently used in oncology centers.
• Organ preservation: Chinese specialists utilize neoadjuvant chemoimmunotherapy to increase laryngeal preservation rates significantly.
• Facility access: Specialized centers like Fuda Cancer Hospital in Guangzhou offer advanced oncology care.

Bookimed Expert Insight: China has become a global leader in domestic PD-1 drug development. Clinics like Xiamen Humanity Hospital are even accredited for Phase I-IV drug trials. This means patients often access the latest immunotherapy protocols through clinical trials or early-access domestic medications. These domestic drugs frequently cost up to 85% less than international brands including nivolumab.

Patient Consensus: Patients note immunotherapy often enters the conversation quickly once surgery or radiation options are exhausted. They emphasize visiting major hubs like Guangzhou or Beijing to find oncologists experienced in these specific protocols.